fda statement bpc-157 compounding safety risks Excellent news for us on the frontiers of medicine. Bringing back peptides to pharmacies is the long awaited expectation from this administration. I voted for this. In September 2023, the Biden FDA's own advisory committee voted

FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. MORE BELOW The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link Is BPC 157 Legal in 2026? FDA Compounding Status Explained What to Know About Peptides the FDA Is Considering for Use The New York Times

SKU: 98223042271 · From metron-ms.com